Rick Wise is ranked #102 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

STIF

Rick Wise

Q: How accurate are Rick Wise's stock ratings?

About 74% of Rick's ratings were profitable over a one-year hold, with an average return of +12.9% per rating, measured by 13Foresight from historical prices.

Stifel Nicolaus

Wall Street Analyst

★★★★★

#102

on 13Foresight · ranked by our own returns

74%

Success Rate

+12.6%

Average Return

43 of 58 calls profitable · +8.0% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 74% of Rick Wise's ratings turned a profit when each position was held for 1 year — averaging +12.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

114 Buy 21 Hold 0 Sell

Rick's Stock Coverage 29 ratings · 2026-08-14

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
HTFL HeartFlow, Inc.	Aug 14, 2026	BUY	Strong Buy +19.8% avg upside 9 analysts	$45.00 45.17% Upside	+0.0%	·
TMCI Treace Medical Concepts	Aug 11, 2026	HOLD	Hold +32.2% avg upside 8 analysts	$4.50 0.25% Downside	+0.8%	·
BDX Becton Dickinson	Aug 11, 2026	BUY	Buy +7.8% avg upside 25 analysts	$195.00 7.25% Upside	+0.3%	·
AORT Artivion	Aug 07, 2026	BUY	Strong Buy +43.6% avg upside 8 analysts	$45.00 58.41% Upside	+7.4%	·
OM Outset Medical	Aug 07, 2026	BUY	Buy +293.3% avg upside 8 analysts	$6.00 41.20% Upside	-8.0%	·
TSE:PRN Profound Medical	Aug 07, 2026	BUY	Strong Buy +100.4% avg upside 11 analysts	$13.95 49.02% Upside	-10.7%	·
SOLV Solventum Corporation	Aug 06, 2026	BUY	Buy +5.8% avg upside 16 analysts	$100.00 15.68% Upside	+6.8%	·
MDLN Medline	Aug 06, 2026	BUY	Strong Buy +31.8% avg upside 27 analysts	$45.00 26.42% Upside	+3.6%	·
ZBH Zimmer Biomet Holdings	Aug 06, 2026	BUY	Buy +15.1% avg upside 38 analysts	$110.00 10.55% Upside	+3.6%	·
LMAT Lemaitre Vascular	Aug 05, 2026	BUY	Strong Buy +22.1% avg upside 15 analysts	$120.00 46.51% Upside	+4.3%	·
KIDS OrthoPediatrics	Aug 05, 2026	BUY	Strong Buy +25.3% avg upside 10 analysts	$24.00 4.00% Downside	+11.2%	·
LIVN LivaNova	Aug 05, 2026	BUY	Strong Buy -0.9% avg upside 15 analysts	$85.00 3.37% Upside	+5.2%	·
BAX Baxter International	Jul 31, 2026	HOLD	Buy +23.8% avg upside 23 analysts	$28.00 3.43% Upside	+3.4%	·
LUNG Pulmonx	Jul 30, 2026	BUY	Buy +236.5% avg upside 9 analysts	$2.50 15.71% Upside	+50.3%	·
GEHC GE Healthcare Technologies Inc	Jul 30, 2026	BUY	Strong Buy +11.5% avg upside 22 analysts	$80.00 8.47% Upside	+5.4%	·
BSX Boston Scientific	Jul 29, 2026	BUY	Strong Buy +31.1% avg upside 38 analysts	$60.00 16.12% Upside	+11.7%	·
EW Edwards Lifesciences	Jul 24, 2026	BUY	Strong Buy +8.5% avg upside 34 analysts	$110.00 18.90% Upside	+10.9%	·
ATRC Atricure	Jul 24, 2026	BUY	Strong Buy +5.6% avg upside 13 analysts	$50.00 14.99% Upside	+26.4%	·
ISRG Intuitive Surgical	Jul 17, 2026	BUY	Strong Buy +19.8% avg upside 36 analysts	$550.00 36.97% Upside	+14.2%	·
JNJ Johnson & Johnson	Jul 15, 2026	HOLD	Strong Buy -9.2% avg upside 39 analysts	$260.00 0.73% Downside	+5.4%	·
KMTS Kestra Medical Technologies Ltd.	Jul 15, 2026	BUY	Strong Buy +1.8% avg upside 9 analysts	$30.00 8.07% Upside	+13.9%	·
MDT Medtronic	Jun 03, 2026	HOLD	Buy +6.4% avg upside 38 analysts	$80.00 11.67% Downside	+18.8%	·
SYK Stryker	May 01, 2026	BUY	Strong Buy +8.2% avg upside 37 analysts	$360.00 5.61% Upside	+16.0%	·
ABT Abbott Laboratories	Apr 17, 2026	BUY	Strong Buy +4.4% avg upside 36 analysts	$120.00 7.82% Upside	+13.0%	·
CNMD Conmed	May 01, 2025	HOLD	Hold +30.6% avg upside 12 analysts	$55.00 10.45% Upside	-35.2%	·
VRAYQ Viewray	Jun 03, 2023	HOLD	Strong Buy +558333233.3% avg upside 12 analysts	$1.00 99999899.99% Upside	·	·
HIND Vyome Holdings	Feb 25, 2019	BUY	Strong Buy +1359.8% avg upside 8 analysts	$30.00 1288.82% Upside	·	·
TNDM Tandem Diabetes Care	Aug 22, 2018	HOLD	Buy +41.5% avg upside 29 analysts	$34.00 46.91% Upside	+77.7%	·
IDXX Idexx Laboratories	Nov 08, 2012	HOLD	Buy +27.4% avg upside 17 analysts	—	+21.9%	·

🔒 24 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Rick Wise — Frequently Asked Questions

How accurate are Rick Wise's stock ratings?

Based on the calls 13Foresight could measure, about 74% of Rick's ratings were profitable over a one-year hold, with an average return of +12.9% per rating, or +8.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Rick ranked on 13Foresight?

Rick Wise is currently ranked #102 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Rick cover?

Rick most recently has ratings on HTFL, TMCI, BDX, AORT, OM, TSE:PRN, SOLV, MDLN, ZBH, LMAT, KIDS, LIVN and 17 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rick Wise

Rating Distribution

Welcome to 13Foresight!